What can be expected from gene therapy in respiratory diseases?
Mornex, J.F.
Presse Medicale 27(16): 769-770
1998
ISSN/ISBN: 0755-4982 PMID: 9767903 Document Number: 488602
Document emailed within 1 workday
Related Documents
1994: Glucocorticoid therapy in obstructive respiratory tract diseases. German Respiratory League Pneumologie 48 Suppl. 1: 334-337Takami, H. 2006: Home respiratory management--an attempt at respiratory physical therapy for neuromuscular diseases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(Suppl 2): 246-247
Adam, D.; Ferlinz, R.; Frei, R.; Geisler, L.; Knothe, H.; Lode, H.; Shah, P. 1992: Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases Medizinische Monatsschrift für Pharmazeuten 15(4): 100-105
Prystupa, L.N.; Garbuzova, V.Y.; Kmyta, V.V. 2015: Bcl1 Polymorphism of Glucocorticoid Receptor Gene and Respiratory Diseases Likars'ka Sprava 2015(1-2): 43-48
Yanagihara, K. 2007: Gene therapy for respiratory tract infection Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 3): 642-647
Yanagihara, K. 2005: Gene therapy for respiratory tract infection Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 617-621
Yoshimura, K.; Tanabe, O. 1996: Structure and expression of the human neutrophil elastase gene--regulatory mechanism and its relevance to the respiratory diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 54(2): 396-404
Benndorf, S.; Meyer, F.P.; Walther, H. 1975: Ambulatory treatment of virus-induced respiratory tract diseases. 4. Clinical aspects and therapy of virus-induced respiratory tract infections as well as the developmental aspects of antiviral therapy Zeitschrift für Arztliche Fortbildung 69(22): 1153-1162
Szczuka, I.; Leowski, J.; Miller, M.; Werens, S. 1978: Epidemiologic studies on respiratory diseases in Płock. IV. Selected environmental factors and symptoms of chronic non-specific respiratory diseases Pneumonologia Polska 46(9): 647-653
Cegla, U.H. 1985: Physical therapy in respiratory diseases Fortschritte der Medizin 103(23): 619-621
Viet Tran, H.; Schorderet, D.F.; Kostic, C.; Munier, F.L.; Arsenijevic, Y. 2009: Gene therapy for hereditary eye diseases: where are we? Revue Medicale Suisse 5(186): 118-123
Attramadal, H.; Berg, K. 2001: Gene therapy in cardiovascular diseases Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(4): 489-491
Sangro, B.; Ruiz, J.; Qian, C.; Prieto, J. 2000: Gene therapy for liver diseases Gastroenterologia y Hepatologia 23(8): 394-402
Svoboda, J. 1996: Retroviruses and retroelements in diseases and in gene therapy Folia Biologica 42(6): 283-294
Ohashi, T. 2010: Gene therapy for lysosomal storage diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 665-669
Wolfsdorf, J. 1971: Mist therapy--its application in respiratory diseases in childhood Therapeutische Umschau. Revue Therapeutique 28(11): 756-760
Fan, L.; Jiang, X.-g. 2010: Development of gene therapy in major brain diseases Yao Xue Xue Bao 45(9): 1095-1102
Mazzolini, G.; Ruiz, J.; Qian, C.; Prieto, J. 2001: Gene therapy: its contributions to liver and kidney diseases Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 21(Suppl 1): 17-23
Heinl, K.W. 1989: Obstructive respiratory tract diseases. Diagnosis and principles of therapy Medizinische Monatsschrift für Pharmazeuten 12(11): 338-343
Schilling, W.; Jastroch, S.; Lindroos, H. 1992: Glucocorticosteroid inhalation therapy of respiratory tract and lung diseases Zeitschrift für Arztliche Fortbildung 86(10): 483-493